Form 8-K - Current report:
SEC Accession No. 0001104659-26-027953
Filing Date
2026-03-16
Accepted
2026-03-16 07:08:09
Documents
16
Period of Report
2026-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm268876d1_8k.htm   iXBRL 8-K 40678
2 EXHIBIT 4.1 tm268876d1_ex4-1.htm EX-4.1 88847
3 EXHIBIT 10.1 tm268876d1_ex10-1.htm EX-10.1 236642
4 EXHIBIT 10.2 tm268876d1_ex10-2.htm EX-10.2 109738
5 EXHIBIT 99.1 tm268876d1_ex99-1.htm EX-99.1 14796
9 GRAPHIC tm268876d1_ex99-1img001.jpg GRAPHIC 5421
  Complete submission text file 0001104659-26-027953.txt   783019

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA anro-20260316.xsd EX-101.SCH 3038
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE anro-20260316_lab.xml EX-101.LAB 34239
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anro-20260316_pre.xml EX-101.PRE 22374
19 EXTRACTED XBRL INSTANCE DOCUMENT tm268876d1_8k_htm.xml XML 3219
Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41944 | Film No.: 26754433
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)